Items where Author is "Ali, Haris"

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | No Grouping
Number of items: 3.

Article

Meyers, Gabrielle and Hamadani, Mehdi and Martens, Michael and Ali, Haris and Chevallier, Patrice and Choe, Hannah and Harris, Andrew C. and Holler, Ernst and van Hooren, Eric and Klaassen, Willem and Leifer, Eric and van Oosterhout, Ypke and Perez, Lia and Pusic, Iskra and Stelljes, Matthias and van der Velden, Walter and Ammatuna, Emanuele and Beauvais, David and Cornillon, Jerome and Maziarz, Richard T. and Schetelig, Johannes and Romeril, Jennifer and Macmillan, Margaret L. and Levine, John E. and Socie, Gerard (2025) Correction: Anti-CD3/CD7 immunoconjugate (T-Guard) for severe, steroid-refractory GVHD: final report of BMT CTN 2002 (vol 58, pg 1416, 2023). BONE MARROW TRANSPLANTATION, 60 (5). p. 746. ISSN 0268-3369, 1476-5365

Meyers, Gabrielle and Hamadani, Mehdi and Martens, Michael and Ali, Haris and Chevallier, Patrice and Choe, Hannah and Harris, Andrew C. and Holler, Ernst and van Hooren, Eric and Klaassen, Willem and Leifer, Eric and van Oosterhout, Ypke and Perez, Lia and Pusic, Iskra and Stelljes, Matthias and van der Velden, Walter and Ammatuna, Emanuele and Beauvais, David and Cornillon, Jerome and Maziarz, Richard T. and Schetelig, Johannes and Romeril, Jennifer and MacMillan, Margaret L. and Levine, John E. and Socie, Gerard (2023) Anti-CD3/CD7 immunoconjugate (T-Guard) for severe, steroid-refractory GVHD: final report of BMT CTN 2002. BONE MARROW TRANSPLANTATION, 58. pp. 1416-1418. ISSN 0268-3369, 1476-5365

Conference or Workshop Item

Im, Annie and Wolff, Daniel and Cutler, Corey and Zeiser, Robert and Shah, Nirav N. and Tan, Ming Tony and Sanz, Jaime and Ali, Haris and Milone, Giuseppe and LaW, Arjun D. and Russo, Domenico and Wagner, Eva-Maria and Ivanova, Olga and Hou, Kevin and Bleam, Maureen and Morariu-Zamfir, Rodica and Pavletic, Steven Z. (2022) Itacitinib and Corticosteroids As Initial Treatment for Chronic Graft-Versus-Host Disease: Phase 1/2 Results from Gravitas-309. In: 64th Annual Meeting and Exposition of the American Society of Hematology (ASH), December 10-13, 2022, New Orleans, LA.

This list was generated on Wed Oct 21 11:33:26 2026 CEST.